Frontiers in Pharmacology is delighted to present the ‘Reviews in’ series of article collections.
The Reviews in Experimental Pharmacology and Drug Discovery 2023 collection aims to provide a comprehensive overview of the latest advancements and research in the pharmacological management of non-communicable diseases (NCDs). NCDs, such as cardiovascular diseases, cancer, diabetes, Alzheimer's disease, and respiratory conditions, have become a critical public health concern worldwide due to their long-term impact on individuals, communities, and economies. Through a deeper understanding of the underlying mechanisms and the development of novel therapeutic strategies, we aim to contribute to the improvement of patient outcomes, the reduction of disease burden, and the overall enhancement of public health.
NCDs have emerged as a global epidemic, accounting for the majority of morbidity and mortality worldwide. The rising prevalence of NCDs necessitates a dedicated focus on improving pharmacotherapy options to enhance patient outcomes. By exploring the underlying mechanisms and targets involved in NCDs, this collection seeks to provide researchers, clinicians, and healthcare professionals with invaluable insights into developing effective therapeutic interventions.
The collection welcomes full-length, mini or systematic review papers, including, but not limited to, the following topics:
1. Pharmacological interventions targeting specific pathways implicated in NCDs.
2. Novel drug discovery and development approaches for NCDs.
3. Exploring the potential of precision medicine and personalized therapeutics in NCD management.
4. Investigating the role of drug metabolism and pharmacokinetics in optimizing treatments.
5. Innovative drug delivery systems to enhance therapeutic efficacy and patient compliance.
6. Harnessing the power of emerging technologies, such as artificial intelligence and high-throughput screening, in drug discovery for NCDs.
By gathering knowledge from diverse sources, this collection aims to stimulate collaboration, foster innovation, and ultimately drive progress in the field of Experimental Pharmacology and Drug Discovery.
Frontiers in Pharmacology is delighted to present the ‘Reviews in’ series of article collections.
The Reviews in Experimental Pharmacology and Drug Discovery 2023 collection aims to provide a comprehensive overview of the latest advancements and research in the pharmacological management of non-communicable diseases (NCDs). NCDs, such as cardiovascular diseases, cancer, diabetes, Alzheimer's disease, and respiratory conditions, have become a critical public health concern worldwide due to their long-term impact on individuals, communities, and economies. Through a deeper understanding of the underlying mechanisms and the development of novel therapeutic strategies, we aim to contribute to the improvement of patient outcomes, the reduction of disease burden, and the overall enhancement of public health.
NCDs have emerged as a global epidemic, accounting for the majority of morbidity and mortality worldwide. The rising prevalence of NCDs necessitates a dedicated focus on improving pharmacotherapy options to enhance patient outcomes. By exploring the underlying mechanisms and targets involved in NCDs, this collection seeks to provide researchers, clinicians, and healthcare professionals with invaluable insights into developing effective therapeutic interventions.
The collection welcomes full-length, mini or systematic review papers, including, but not limited to, the following topics:
1. Pharmacological interventions targeting specific pathways implicated in NCDs.
2. Novel drug discovery and development approaches for NCDs.
3. Exploring the potential of precision medicine and personalized therapeutics in NCD management.
4. Investigating the role of drug metabolism and pharmacokinetics in optimizing treatments.
5. Innovative drug delivery systems to enhance therapeutic efficacy and patient compliance.
6. Harnessing the power of emerging technologies, such as artificial intelligence and high-throughput screening, in drug discovery for NCDs.
By gathering knowledge from diverse sources, this collection aims to stimulate collaboration, foster innovation, and ultimately drive progress in the field of Experimental Pharmacology and Drug Discovery.
